Balance Sheet

v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2025
Jun. 30, 2025
Current assets    
Cash $ 1,616,765 $ 2,975,150
Accounts receivable, net 594,552 157,515
Inventory, net 728,273 1,152,870
Due from VitaMedica transition 304,880 228,017
Prepaid expenses and other receivables 1,302,064 350,836
Current digital assets at fair value 164,703,917 49,913,655
Purchase price receivable - VitaMedica 2,000,000 2,000,000
Total current assets 171,250,451 56,778,043
Property and equipment, net 543,246 2,052,573
Intangible assets, net 874,733 163,113
Goodwill 673,854 848,854
Deferred tax asset 5,948,858 5,948,858
Digital assets at fair value, net of current 90,998,464 56,083,525
Other assets 218,710 192,123
Right-of-use asset, net 636,449 1,739,755
Total other assets 99,894,314 67,028,801
Total assets 271,144,765 123,806,844
Current liabilities    
Accounts payable 665,840 1,039,370
Accrued compensation 3,111,115 3,470,296
Deferred revenue 47,287 13,155
Accrued liabilities 1,964,281 356,064
Accrued interest 2,902,942 792,449
Acquisition payable 260,652 260,652
Current portion of promissory notes 560,000 560,000
Short-term treasury debt 62,695,723 20,000,000
Current portion of Cygnet subsidiary notes payable 5,380,910 5,380,910
Current portion of operating lease payable 263,672 691,010
Total current liabilities 77,852,422 32,563,906
Operating lease payable, net of current portion 460,134 1,145,440
Convertible notes payable 144,115,480 0
Total long-term liabilities 144,575,614 1,145,440
Stockholders' equity    
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, and 150,000 and 150,000 shares issued and outstanding, respectively 2 2
Common stock, $0.00001 par value, 1,000,000,000 shares authorized, 63,212,588 and 38,270,571 shares issued, as of December 31, 2025 and June 30, 2025, respectively 632 383
Treasury stock, 416,226 and 0, as of December 31, 2025 and June 30, 2025, respectively (799,277) 0
Additional paid in capital 222,236,002 150,640,935
Accumulated deficit (172,720,630) (60,543,822)
Total stockholders' equity 48,716,729 90,097,498
Total liabilities and stockholders' equity $ 271,144,765 $ 123,806,844

Source

PDF HTML
ZIP